Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial

Zubin Punthakee, Michael E Miller, Lenore J Launer, Jeff D Williamson, Ronald M Lazar, Tali Cukierman-Yaffee, Elizabeth R Seaquist, Faramarz Ismail-Beigi, Mark D Sullivan, Laura C Lovato, Richard M Bergenstal, Hertzel C Gerstein, ACCORD Group of Investigators, ACCORD-MIND Investigators, Zubin Punthakee, Michael E Miller, Lenore J Launer, Jeff D Williamson, Ronald M Lazar, Tali Cukierman-Yaffee, Elizabeth R Seaquist, Faramarz Ismail-Beigi, Mark D Sullivan, Laura C Lovato, Richard M Bergenstal, Hertzel C Gerstein, ACCORD Group of Investigators, ACCORD-MIND Investigators

Abstract

Objective: Self-management of type 2 diabetes including avoidance of hypoglycemia is complex, but the impact of cognition on safe self-management is not well understood. This study aimed to assess the effect of baseline cognitive function and cognitive decline on subsequent risk of severe hypoglycemia and to assess the effect of different glycemic strategies on these relationships.

Research design and methods: Prospective cohort analysis of data from the ACCORD trial included 2,956 adults aged ≥55 years with type 2 diabetes and additional cardiovascular risk factors. Cognitive tests (Digit Symbol Substitution Test [DSST], Rey Auditory Verbal Learning Test, Stroop Test, and Mini Mental Status Examination) were conducted at baseline and 20 months. Study outcomes were incident confirmed severe hypoglycemia requiring medical assistance (HMA) and hypoglycemia requiring any assistance (HAA).

Results: After a median 3.25-year follow-up, a 5-point-poorer baseline score on the DSST was predictive of a first episode of HMA (hazard ratio 1.13 [95% CI 1.08-1.18]). Analyses of the other cognitive tests and of HAA were consistent with the DSST results. Cognitive decline over 20 months increased the risk of subsequent hypoglycemia to a greater extent in those with lower baseline cognitive function (P(interaction) = 0.037). Randomization to an intensive versus standard glycemic strategy had no impact on the relationship between cognitive function and the risk of severe hypoglycemia.

Conclusions: Poor cognitive function increases the risk of severe hypoglycemia in patients with type 2 diabetes. Clinicians should consider cognitive function in assessing and guiding their patients regarding safe diabetes self-management regardless of their glycemic targets.

Trial registration: ClinicalTrials.gov NCT00000620.

Figures

Figure 1
Figure 1
Kaplan-Meier curves for HMA according to baseline thirds of the DSST score. Crude incidence rates and 95% CIs are shown for each group. Log-rank test P < 0.0001. HRs for the middle- and highest-score groups are with reference to the lowest–DSST score group.
Figure 2
Figure 2
Effect of 20-month change in DSST score on crude incidence of severe hypoglycemia requiring medical assistance after 20 months, according to baseline thirds of DSST score. Number of individuals in each category is presented above each bar.

References

    1. American Diabetes Association Standards of medical care in diabetes—2009. Diabetes Care 2009;32(Suppl. 1):S13–S61
    1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Organization of Diabetes Care. Canadian Journal of Diabetes 2008;32:S20–S24
    1. International Diabetes Federation Education. In Global Guideline for Type 2 Diabetes. Brussels, International Diabetes Federation, 2005, p. 15–18
    1. McGuire LC, Ford ES, Ajani UA. The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging. BMC Geriatr 2006;6:8.
    1. Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract 2000;50:203–212
    1. Buse JB, Bigger JT, Byington RP, et al. ; ACCORD Study Group Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 2007;99(12A):21i–33i
    1. Gerstein HC, Riddle MC, Kendall DM, et al. ; ACCORD Study Group Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007;99(12A):34i–43i
    1. Williamson JD, Miller ME, Bryan RN, et al. ; ACCORD Study Group The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol 2007;99(12A):112i–122i
    1. Rosano C, Simonsick EM, Harris TB, et al. Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology 2005;24:8–14
    1. Pavlik VN, de Moraes SA, Szklo M, Knopman DS, Mosley TH, Jr, Hyman DJ. Relation between cognitive function and mortality in middle-aged adults: the atherosclerosis risk in communities study. Am J Epidemiol 2003;157:327–334
    1. Swan GE, Carmelli D, LaRue A. Performance on the digit symbol substitution test and 5-year mortality in the Western Collaborative Group Study. Am J Epidemiol 1995;141:32–40
    1. Proust-Lima C, Amieva H, Dartigues JF, Jacqmin-Gadda H. Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies. Am J Epidemiol 2007;165:344–350
    1. Lezak MD. Memory I: tests. In Neuropsychological Assessment. New York, Oxford University Press, 1995, p. 429–498
    1. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643–662
    1. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922–935
    1. Cukierman-Yaffe T, Gerstein HC, Williamson JD, et al. ; Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 2009;32:221–226
    1. Miller ME, Bonds DE, Gerstein HC, et al. ; ACCORD Investigators The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010;340:b5444.
    1. Patel A, MacMahon S, Chalmers J, et al. ; ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560–2572
    1. Gerstein HC, Miller ME, Byington RP, et al. ; Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559
    1. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008;29:494–511
    1. Brumback T, Cao D, King A. Effects of alcohol on psychomotor performance and perceived impairment in heavy binge social drinkers. Drug Alcohol Depend 2007;91:10–17
    1. Lukas SE, Lex BW, Slater JP, Greenwald NE, Mendelson JH. A microanalysis of ethanol-induced disruption of body sway and psychomotor performance in women. Psychopharmacology (Berl) 1989;98:169–175
    1. Heishman SJ, Stitzer ML, Bigelow GE. Alcohol and marijuana: comparative dose effect profiles in humans. Pharmacol Biochem Behav 1988;31:649–655
    1. Beydoun MA, Kaufman JS, Sloane PD, Heiss G, Ibrahim J. n-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the Atherosclerosis Risk in Communities (ARIC) study. Public Health Nutr 2008;11:17–29
    1. Hoyer WJ, Stawski RS, Wasylyshyn C, Verhaeghen P. Adult age and digit symbol substitution performance: a meta-analysis. Psychol Aging 2004;19:211–214
    1. Lee DM, Tajar A, Ulubaev A, et al. ; EMAS study group The association between different cognitive domains and age in a multi-centre study of middle-aged and older European men. Int J Geriatr Psychiatry 2009;24:1257–1266
    1. MacDonald SW, Hultsch DF, Strauss E, Dixon RA. Age-related slowing of digit symbol substitution revisited: what do longitudinal age changes reflect? J Gerontol B Psychol Sci Soc Sci 2003;58:187–194
    1. Wielgos CM, Cunningham WR. Age-related slowing on the Digit Symbol task: longitudinal and cross-sectional analyses. Exp Aging Res 1999;25:109–120
    1. de Galan BE, Zoungas S, Chalmers J, et al. ; ADVANCE Collaborative Group Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009;52:2328–2336
    1. Austin EJ, Deary IJ. Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care 1999;22:1273–1277
    1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986
    1. Cox DJ, Kovatchev B, Koev D, et al. Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int J Behav Med 2004;11:212–218
    1. Misono AS, Cutrona SL, Choudhry NK, et al. Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence. Am J Manag Care 2010;16(Suppl. HIT):SP82–SP92

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다